GHK-CU 100mg

Contents

Use this guide as a structured review page. The same headings appear for every protocol so clients and the care team can scan the page consistently.

Quickstart Highlights

GHK-Cu (glycyl-L-histidyl-L-lysine:copper complex) is a naturally occurring copper peptide with documented roles in wound healing, tissue remodeling, and skin regeneration[1][2]. Research demonstrates activity in gene regulation related to collagen synthesis, antioxidant defense, and anti-inflammatory pathways[3][4]. This educational protocol presents practical subcutaneous administration approaches based on clinical practice patterns.

• Reconstitute: Add 3.0 mL sterile water → 33.3 mg/mL concentration.
• Typical range: 1–2 mg per injection (most common protocols use 5 days/week or 3×/week).
• Easy measuring: At 33.3 mg/mL, 1 unit = 0.01 mL ≈ 333 mcg on a U‑100 insulin syringe.
• Storage: Lyophilized: store at −20 °C (−4 °F) or below; reconstituted: refrigerate at 2–8 °C (35.6–46.4 °F) and use within 30 days.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

• Frequency: Inject once daily, 5 days per week subcutaneously[5][6]. This gradual titration allows assessment of individual tolerance while maintaining practical injection volumes. For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.

Reconstitution Steps

Frequency: Inject 2 mg three times per week (e.g., Monday/Wednesday/Friday)[6]. This protocol maintains consistent weekly dosing (~6 mg/week) with less frequent injections.

• Draw 3.0 mL sterile or bacteriostatic water with a sterile syringe.
• Inject slowly down the vial wall to minimize foaming.
• Gently swirl or roll the vial until the peptide fully dissolves (do not shake vigorously).
• Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on an 8–16 week protocol. Calculations shown for both 5 days/week and 3×/week protocols.

• Peptide Vials (GHK-Cu, 100 mg each):
• Peptide Vials (GHK-Cu, 100 mg each):: 5 days/week (1–2 mg/day):
• Peptide Vials (GHK-Cu, 100 mg each):: 8 weeks (~80 mg total) ≈ 1 vial
• Peptide Vials (GHK-Cu, 100 mg each):: 12 weeks (~120 mg total) ≈ 2 vials
• Peptide Vials (GHK-Cu, 100 mg each):: 16 weeks (~160 mg total) ≈ 2 vials
• Peptide Vials (GHK-Cu, 100 mg each):: 3×/week (2 mg each):
• Peptide Vials (GHK-Cu, 100 mg each):: 8 weeks (~48 mg) ≈ 1 vial
• Peptide Vials (GHK-Cu, 100 mg each):: 12 weeks (~72 mg) ≈ 1 vial
• Peptide Vials (GHK-Cu, 100 mg each):: 16 weeks (~96 mg) ≈ 1 vial
• Insulin Syringes (U‑100, 29–31 gauge):
• Insulin Syringes (U‑100, 29–31 gauge):: 5 days/week:
• Insulin Syringes (U‑100, 29–31 gauge):: Per week: 5 syringes
• Insulin Syringes (U‑100, 29–31 gauge):: 8 weeks: 40 syringes
• Insulin Syringes (U‑100, 29–31 gauge):: 12 weeks: 60 syringes
• Insulin Syringes (U‑100, 29–31 gauge):: 16 weeks: 80 syringes
• Insulin Syringes (U‑100, 29–31 gauge):: 3×/week:
• Insulin Syringes (U‑100, 29–31 gauge):: Per week: 3 syringes
• Insulin Syringes (U‑100, 29–31 gauge):: 8 weeks: 24 syringes
• Insulin Syringes (U‑100, 29–31 gauge):: 12 weeks: 36 syringes
• Insulin Syringes (U‑100, 29–31 gauge):: 16 weeks: 48 syringes
• Sterile or Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
• Sterile or Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 1 vial protocols: 3 mL → 1 × 10 mL bottle
• Sterile or Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 2 vial protocols: 6 mL → 1 × 10 mL bottle
• Alcohol Swabs: One for the vial stopper + one for the injection site each administration.
• Alcohol Swabs: One for the vial stopper + one for the injection site each administration.: 5 days/week:
• Alcohol Swabs: One for the vial stopper + one for the injection site each administration.: Per week: 10 swabs (2 per injection)
• Alcohol Swabs: One for the vial stopper + one for the injection site each administration.: 8 weeks: 80 swabs → recommend 1 × 100‑count box
• Alcohol Swabs: One for the vial stopper + one for the injection site each administration.: 12 weeks: 120 swabs → recommend 2 × 100‑count boxes
• Alcohol Swabs: One for the vial stopper + one for the injection site each administration.: 16 weeks: 160 swabs → recommend 2 × 100‑count boxes
• Alcohol Swabs: One for the vial stopper + one for the injection site each administration.: 3×/week:
• Alcohol Swabs: One for the vial stopper + one for the injection site each administration.: Per week: 6 swabs
• Alcohol Swabs: One for the vial stopper + one for the injection site each administration.: 8 weeks: 48 swabs → recommend 1 × 100‑count box
• Alcohol Swabs: One for the vial stopper + one for the injection site each administration.: 12 weeks: 72 swabs → recommend 1 × 100‑count box
• Alcohol Swabs: One for the vial stopper + one for the injection site each administration.: 16 weeks: 96 swabs → recommend 1 × 100‑count box

Protocol Overview

Concise summary of common GHK-Cu administration patterns.

• Goal: Support tissue remodeling, wound healing, and skin regeneration through documented biological pathways[1][2]. Open source
• Schedule: Subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
• Dose Range: 1–2 mg per injection; frequency 3–5 days per week.
• Reconstitution: 3.0 mL per 100 mg vial (33.3 mg/mL) provides practical unit measurements.
• Storage: Lyophilized frozen; reconstituted refrigerated and used within 30 days.

Dosing Protocol

Flexible approaches based on clinical practice patterns.

• Conservative (5 days/week): Start 1 mg daily; titrate to 1.5–2 mg over 4–8 weeks.
• Alternative (3×/week): Consistent 2 mg per injection for simplified scheduling.
• Route: Subcutaneous injection (abdomen, thighs, or upper arms).
• Cycle Length: 8–12 weeks typical; may extend to 16 weeks based on individual goals.
• Timing: Any consistent time of day; rotate injection sites systematically.

Storage Instructions

Proper storage maintains peptide stability and potency.

• Lyophilized (dry powder): Store at −20 °C (−4 °F) or lower in dry, dark conditions[7][8]. Keep vial tightly sealed with desiccant if possible to minimize moisture exposure. Open source
• Reconstituted (in solution): Refrigerate at 2–8 °C (35.6–46.4 °F) and use within 30 days for optimal potency[9]. Bacteriostatic water helps inhibit bacterial growth. Open source
• Aliquoting: For longer storage, divide solution into sterile vials and freeze at −20 °C (−4 °F)[10]. Avoid repeated freeze–thaw cycles as they degrade peptides over time[11]. Open source
• Allow vials to reach room temperature before opening to reduce condensation.

Important Notes

Practical considerations for safe and consistent administration.

• Use new sterile insulin syringes for each injection; dispose in proper sharps containers.
• Rotate injection sites (abdomen at least 1 inch from navel, outer thighs, upper arms) to prevent irritation and lipodystrophy[12][13]. Open source
• Clean injection site with alcohol swab and allow to air-dry completely before injecting[14]. Open source
• Inject slowly and steadily; withdraw needle at same angle as insertion.
• Document dose, date, and injection site to maintain consistency and track rotation.

How This Works

GHK-Cu is a naturally occurring tripeptide that complexes with copper ions to modulate numerous biological processes. Research has demonstrated its involvement in wound healing through enhanced collagen and decorin gene expression[1], activation of tissue remodeling pathways[2], and regulation of genes associated with antioxidant defense and anti-inflammatory responses[3][4]. Preclinical studies show GHK-Cu is active at very low doses in animals (approximately 0.5 mcg/kg in rodent models)[15], while clinical practice employs milligram-range dosing in humans to achieve systemic effects[5][6]. The peptide demonstrates multifunctional activity across skin, nervous system, and vascular tissue, with documented gene-regulatory effects that extend beyond simple wound healing[3][16].

Potential Benefits & Side Effects

Documented effects from research literature and clinical observations.

• Supports wound healing and tissue repair through collagen synthesis and remodeling pathways[1][2]. Open source
• Demonstrates positive regulatory effects on genes related to antioxidant enzymes, growth factors, and anti-inflammatory signaling[3][4]. Open source
• Shows activity in nervous system function and cognitive pathways in preclinical models[16]. Open source
• Generally well tolerated; most common side effects are mild injection-site reactions (temporary redness, itching) with subcutaneous administration.
• No official human dosing guidelines exist as GHK-Cu is not FDA-approved; protocols are based on clinical practice and empirical use[5]. Open source

Lifestyle Factors

Complementary approaches to support tissue health and regeneration.

• Maintain adequate protein intake to support collagen synthesis and tissue repair processes.
• Ensure sufficient hydration and micronutrient status (particularly copper, zinc, vitamin C) for optimal connective tissue metabolism.
• Prioritize sleep quality and stress management to support regenerative biological processes.
• Consider combining with appropriate skincare or wound-care protocols as relevant to individual goals.

Injection Technique

Standard subcutaneous injection guidance from clinical best practices[17][18].

• Clean the vial stopper and injection site with alcohol swabs; allow both to air-dry completely[14]. Open source
• Pinch a fold of skin and insert the needle at 45–90° angle into subcutaneous tissue[17][18]. Open source
• Do not aspirate for subcutaneous injections; inject slowly and steadily[17]. Open source
• Withdraw the needle at the same angle as insertion; if needed, gently press site with cotton swab (do not rub)[19]. Open source
• Rotate injection sites systematically to prevent lipohypertrophy and local irritation[12][13]. Open source
• Dispose of used syringes immediately in a proper sharps container[19]. Open source

Recommended Source

We recommend Prime Lab Peptides for high‑purity GHK-Cu (100 mg).

• High‑purity peptides with third‑party testing and batch-specific Certificates of Analysis.
• Consistent quality control and documentation aligned with research-grade standards.
• Reliable fulfillment with proper cold‑chain handling to maintain peptide integrity.
• Shop at Prime Lab Peptides

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

• Do not start, stop, combine, or change a protocol based only on website content.
• Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References

— GHK-Cu stimulates collagen synthesis in dermal fibroblasts and wound healing processes

• GHK-Cu (100 mg Vial) Open source
• Journal of Dermatological Science — GHK-Cu stimulates collagen synthesis in dermal fibroblasts and wound healing processes View Source Open source
• Wound Repair and Regeneration (Wiley) — Copper peptides in wound healing: tissue remodeling and collagen gene expression View Source Open source
• International Journal of Molecular Sciences (PMC) — Regenerative and protective actions of GHK-Cu: gene regulation analysis View Source Open source
• Biomaterials (Elsevier) — GHK modulation of metalloproteinases and tissue inhibitors in wound healing View Source Open source
• Dr Oracle AI — Clinical dosing patterns for GHK-Cu (1–2 mg subcutaneous protocols) View Source Open source
• Salhab Pharmacy (Compounding Guidelines) — GHK-Cu injection protocols: 5 days/week and 3×/week dosing patterns View Source Open source
• GenScript — Peptide storage and handling guidelines: lyophilized storage at −20 °C (−4 °F) View Source Open source
• Peptide Sciences — Peptide storage best practices: temperature, humidity, and light protection View Source Open source
• Happy Hormones MD (PDF) — GHK-Cu patient information: reconstituted storage at 2–8 °C (35.6–46.4 °F), 30-day use window View Source Open source
• Tocris Bioscience — Stability and storage: aliquoting peptide solutions to minimize freeze-thaw damage View Source Open source
• GenScript — Avoiding repeated freeze-thaw cycles to prevent peptide degradation View Source Open source
• Roswell Park Comprehensive Cancer Center — Injection site rotation to prevent lipodystrophy and local irritation View Source Open source
• Roswell Park Comprehensive Cancer Center — Subcutaneous injection site selection: abdomen, thighs, upper arms View Source Open source
• Roswell Park Comprehensive Cancer Center — Proper skin preparation: alcohol swab cleaning and air-drying before injection View Source Open source
• International Journal of Molecular Sciences (PMC) — Preclinical studies: GHK-Cu activity at low doses (~0.5 mcg/kg in rats) View Source Open source
• Brain Sciences (MDPI) — GHK effect on gene expression relevant to nervous system function and cognitive decline View Source Open source
• CDC — Vaccine administration: subcutaneous injection technique (angle, no aspiration) View Source Open source
• CDC (Subcutaneous Injection PDF) — Technique diagram and site guidance for subcutaneous injections View Source Open source
• NCBI Bookshelf — Best practices for injection: asepsis, preparation, administration, and sharps disposal View Source Open source
• Prime Lab Peptides — GHK-Cu (100 mg) product page: quality documentation and batch testing View Source Open source
• — Copper peptides in wound healing: tissue remodeling and collagen gene expression